As the 2020 campaign kicks off, Democrats scramble to prove their leadership on lowering drug costs
(By Lev Facher for STAT) WASHINGTON — As they jostle to position themselves for 2020, many Democratic presidential hopefuls have
Read More
Part D/Prescription Drugs
As Congress returns, lawmakers rush to detail drug-pricing agendas
(By Lev Facher for STAT) WASHINGTON — Chuck Grassley wasted little time this week in unveiling his drug-pricing agenda, attaching his
Read MoreHospital-owned drug company attracts 12 more health systems
(By Ayla Ellison for Becker’s Hospital Review) Twelve additional health systems have joined Civica Rx, a nonprofit company formed by hospitals to
Read MoreMedicare Advantage Open Enrollment period running now through March 31
Beneficiaries with Medicare Advantage, also known as Medicare Part C, can switch to a new Medicare Advantage plan or can
Read MorePrescription Drug Costs Driven By Manufacturer Price Hikes, Not Innovation
(By Alison Kodjak for NPR) The skyrocketing cost of many prescription drugs in the U.S. can be blamed primarily on
Read MoreExtreme Temperatures May Pose Risks To Some Mail-Order Meds
(By Alex Smith for NPR) Take a look at your prescription bottles. Most say, “Store at room temperature” or “Keep
Read MoreHealth Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment
(ByLiz Szabo for Kaiser Health News) Hoping to earn its share of the $3.5 trillion health care market, the medical industry is
Read MoreHealth insurers upcharged Medicare $9B for prescription drug plans
(By Morgan Haefner for Becker’s Hospital Review) Medicare overpaid health insurers $9.1 billion for providing prescription drug plans after they
Read MoreMedicare Advantage Plan “do-over”
Effective this year, if you want to switch to a different Medicare Advantage Plan, you get a change between January
Read MoreEli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics
(By Matthew Herper for STAT) Eli Lilly, the Indianapolis-based drug giant, said Monday that it will purchase Loxo Oncology, a
Read More